Quantcast

Tag Archives: HRT litigation

Jury awards $5 million in HRT-breast cancer case

A woman who developed breast cancer after taking combination hormone therapy drugs including Premarin, Provera and Prempro for 15 years won a $5 million award against drug companies Wyeth and Upjohn this month.

Read More »

Pa. court reinstates $28M punitive award in HRT case

A $28 million award of punitive damages was not unconstitutionally excessive in a product liability case brought by a woman who contracted breast cancer after taking hormone replacement therapy drugs, a Pennsylvania appellate court has ruled in reversing judgment.

Read More »